Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation.

Sugimachi, K; Matsumura, T; Hirata, H; Uchi, R; Ueda, M; Ueo, H; Shinden, Y; Iguchi, T; Eguchi, H; Shirabe, K; Ochiya, T; Maehara, Y; Mimori, K

doi:10.1038/bjc.2014.621

Public

Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation.

Published in British journal of cancer • Feb 3, 2015

NobleIDark:/48914/w1/20260517/F47A553FRecord on NobleID

Authors:

K Sugimachi

,

T Matsumura

,

H Hirata

Abstract

BACKGROUND: Predictive biomarkers for the recurrence of hepatocellular carcinoma (HCC) have great benefit in the selection of treatment options, including liver transplantation (LT), for HCC. The purpose of this study was to identify specific microRNAs (miRs) in exosomes from the serum of patients w...

Discussions